Skip to main content
Log in

Helicobacter pylori infection and molecular changes in gastric carcinogenesis

  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

In recent years there has been much progress in understanding the pathogenesis of gastric cancer. The role of individual factors in gastric carcinogenesis continues to be debated and is also subject to further analysis. In addition to the activation of oncogenes and the inactivation of tumor suppressor genes, alteration of adhesion molecules seems to be critical for the development of gastric cancer.Helicobacter pylori has been linked to an increased risk of developing gastric cancer, and the molecular changes induced byH. pylori are currently being investigated. Recent studies indicate thatH. pylori induces cell proliferation and apoptosis during the early phase of chronic inflammation of the gastric mucosa, whereas in the malignant transformation of the gastric mucosa apoptosis is inhibited and adhesion of gastric epithelial cells is impaired. This review focuses on the role ofH. pylori in the development of molecular changes in gastric cancer and its preneoplastic lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wright PA, Williams GT. Molecular biology and gastric carcinoma. Gut 1993;34:145–7.

    Article  PubMed  CAS  Google Scholar 

  2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.Helicobacter pylori. In: Schistosomes, liver flukes andHelicobacter pylori: views and expert opinions of an IARC working group on the evaluation of carcinogenic risks to humans. Lyon: IARC, 1994. p. 177–240.

    Google Scholar 

  3. Nomura AMY, Stemmerman GN, Chyou P, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma in a population of Japanese-Americans in Hawaii. N Engl J Med 1991;325:1132–6.

    PubMed  CAS  Google Scholar 

  4. Danesh J.Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999;13:851–6.

    Article  PubMed  CAS  Google Scholar 

  5. Eurogast Study Group. An international association betweenHelicobacter pylori infection and gastric cancer. Lancet 1993;341: 1359–62.

    Article  Google Scholar 

  6. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process: first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735–40.

    PubMed  CAS  Google Scholar 

  7. Dixon MF. Atrophy, metaplasia, and dysplasia: a risk for gastric cancer: are they reversible? In: Hunt RH, Tytgat GNJ, editors.Helicobacter pylori; basic mechanisms to clinical cure 1998. Dordrecht: Kluwer, 1998. p. 336–53.

    Google Scholar 

  8. Miehlke S, Hackelsberger A, Meining A, von Arnim U, Müller P, Ochsenkühn T, et al. Histological diagnosis ofHelicobacter pylori gastritis is predictive of a high risk of gastric carcinoma. Int J Cancer 1997;73:837–9.

    Article  PubMed  CAS  Google Scholar 

  9. Meining A, Bayerdörffer E, Müller P, Miehlke S, Lehn N, Hölzel D, et al. Gastric carcinoma risk index in patients infected withHelicobacter pylori. Virchows Arch 1998;432:311–4.

    Article  PubMed  CAS  Google Scholar 

  10. Miehlke S, Kirsch C, Agha-Amiri K, Günther T, Lehn N, Malfertheiner P, et al. TheHelicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer 2000;87:322–7.

    Article  PubMed  CAS  Google Scholar 

  11. Mizutani T, Onda M, Tokunga A, Yamanaka N, Sugisaki Y. Relationship of c-erbB2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. Cancer 1993;72:2083–8.

    Article  PubMed  CAS  Google Scholar 

  12. Park JB, Rhim JS, Park SC, Kimm SW, Kraus MH. Amplification, overexpression and rearrangement of the c-erbB2 protooncogene in primary human stomach carcinomas. Cancer Res 1989;49:6605–9.

    PubMed  CAS  Google Scholar 

  13. Cadena DL, Gill GN. Receptor tyrosine kinases. FASEB J 1992;6:2332–7.

    PubMed  CAS  Google Scholar 

  14. Fujida K, Ohuchi N, Yao T, Okumura M, Fukushima Y, Kanakura Y, et al. Frequent overexpressin, but not activation by point mutation of ras genes in primary human gastric cancers. Gastroenterology 1987;93:1339–45.

    Google Scholar 

  15. Soman NR, Wogan GN, Rhim JS. TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines. Proc Natl Acad Sci USA 1990:87:738–42.

    Article  PubMed  CAS  Google Scholar 

  16. Yu J, Miehlke S, Ebert M, Hoffmann J, Breidert M, Starzynska T, et al. Frequency of the TPR-MET rearrangement in gastric cancer and in a first degree relative. Cancer 2000:88:1801–6.

    Article  PubMed  CAS  Google Scholar 

  17. Ranzani GN, Luinetti O, Padovan LS, Calistri D, Renault B, Burrel M, et al. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol Biomarkers Prev 1995;4: 223–31.

    PubMed  CAS  Google Scholar 

  18. Hsieh LL, Huang YC. Loss of heterozygosity of APC/MCC gene in differentiated and undifferentiated gastric carcinoma in Taiwan. Cancer Lett 1995;96:169–74.

    Article  PubMed  CAS  Google Scholar 

  19. Jawhari A, Farthing M, Pignatelli M. The importance of the Ecadherin-catenin complex in the maintenance of intestinal epithelial homoeostasis: more than intercellular glue? Gut 1997;41: 581–4.

    Article  PubMed  CAS  Google Scholar 

  20. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994;54:3845–52.

    PubMed  CAS  Google Scholar 

  21. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJG. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 1997;112:46–54.

    Article  PubMed  CAS  Google Scholar 

  22. Park WS, Oh RR, Park JY. Frequent somatic mutations of the βcatenin gene in intestinal type gastric cancer. Cancer Res 1999; 59:4257–60.

    PubMed  CAS  Google Scholar 

  23. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159–70.

    Article  PubMed  CAS  Google Scholar 

  24. Ottini L, Palli D, Falchetti M, D’Amico C, Amorosi A, Saieva C, et al. Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 1997;57:4523–9.

    PubMed  CAS  Google Scholar 

  25. Yamamoto H, Perez-Piteira J, Yoshida T, Terada M, Itoh F, Imai K, et al. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 1999;116:1348–57.

    Article  PubMed  CAS  Google Scholar 

  26. Zanghieri G, Di Gregorio C, Sacchetti C, Fante R, Sassatelli R, Cannizzo G, et al. Familial occurrence of gastric cancer and in the 2-year experience of a population-based registry. Cancer 1990;66: 2047–51.

    Article  PubMed  CAS  Google Scholar 

  27. Ebert M, Yu J, Miehlke S, Lendeckel U, Ridwelski K, Stolte M, et al. Expression of transforming growth factor beta 1 in gastric cancer and in the gastric mucosa of first degree relatives of patients with gastric cancer. Br J Cancer 2000;82:1795–800.

    Article  PubMed  CAS  Google Scholar 

  28. Yu J, Ebert M, Miehlke S, Lendeckel U, Stolte M, Malfertheiner P, et al. α-Catenin expression is decreased in gastric cancer and in the gastric mucosa of first degree relatives of patients with gastric cancer. Gut 2000;46:639–44.

    Article  PubMed  CAS  Google Scholar 

  29. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M.Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998;115:642–8.

    Article  PubMed  CAS  Google Scholar 

  30. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development ofHelicobacter pylori induced gastric carcinoma in mongolian gerbils. Cancer Res 1998;58:4225–9.

    Google Scholar 

  31. Fan XG, Kelleher D, Fan XJ, Xia HX, Keeling PWN.Helicobacter pylori increases proliferation of gastric epithelial cells. Gut 1996;38:19–22.

    Article  PubMed  CAS  Google Scholar 

  32. Shirin H, Sordillo EM, Oh SH, Yamamoto H, Delohery T, Weinstein IB, et al.Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells. Cancer Res 1999;59:2277–81.

    PubMed  CAS  Google Scholar 

  33. Terres AM, Pajares JM, O’Toole D, Ahern S, Kelleher D.Helicobacter pylori is associated with downregulation of Ecadherin, a molecule involved in epithelial cell adhesion and proliferation control. J Clin Pathol 1998;51:410–2.

    Article  PubMed  CAS  Google Scholar 

  34. Wu MS, Shun CT, Wang HP, Sheu JC, Lee WJ, Wang TH, et al. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, andHelicobacter pylori infection. Gastroenterology 1997;112:1457–65.

    Article  PubMed  CAS  Google Scholar 

  35. Blok P, Craanen ME, Offerhaus GJ, Dekker W, Kuipers EJ, Meuwissen SG, et al. Molecular alterations in early gastric carcinomas: no apparent correlation withHelicobacter pylori status. Am J Clin Pathol 1999;111:241–7.

    PubMed  CAS  Google Scholar 

  36. Blok P, Craanen ME, Offerhaus GJA, Tytgat GNJ. Gastric carcinoma: clinical, pathogenic and molecular aspects, Q J Med 199790:735–49.

    CAS  Google Scholar 

  37. Rugge M, Shiao YH, Correa P, Baffa R, Dimario F. Immunhistochemical evidence of p53 overexpression in gastric epithelial dysplasia. Cancer Epidemiol Biomarkers Prev 1992;1:551–4.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ebert, M.P.A., Schandl, L. & Malfertheiner, P. Helicobacter pylori infection and molecular changes in gastric carcinogenesis. J Gastroenterol 37 (Suppl 13), 45–49 (2002). https://doi.org/10.1007/BF02990099

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02990099

Key words

Navigation